This article provides an assessment of the downstream impact of coronary artery calcium scanning on the subsequent treatment patterns of non—high-risk patients.
John Barron, PharmD
Advertisement
Articles by John Barron, PharmD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Hans Lee, MD, Discusses “Off-the-Shelf” Solution for Rare Blood Disorder With No Approved Therapies
2
ACP Names Semaglutide, Tirzepatide as First-Line Pharmacotherapy for Obesity
3
AI Billing, GLP-1s Among Forces Driving 9% Health Cost Spike
4
CMS Proposes Permanent Rules for Medicare Drug Price Negotiation
5